Vanguard Group Inc Dexcom Inc Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Dexcom Inc stock. As of the latest transaction made, Vanguard Group Inc holds 49,456,043 shares of DXCM stock, worth $2.87 Billion. This represents 0.05% of its overall portfolio holdings.

Number of Shares

49,456,043

Previous 48,322,405 2.35%

Holding current value

$2.87 Billion

Previous $4.22 Billion 21.1%

% of portfolio

0.05%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$66.46 - $89.53 $75.3 Million - $101 Million	1,133,638 Added 2.35%	49,456,043 $3.33 Billion
Q2 2025 Aug 11, 2025	BUY	$59.83 - $87.57 $51.8 Million - $75.9 Million	866,506 Added 1.83%	48,322,405 $4.22 Billion
Q1 2025 May 09, 2025	BUY	$67.74 - $90.75 $62.7 Million - $84 Million	925,882 Added 1.99%	47,455,899 $3.24 Billion
Q4 2024 Feb 11, 2025	SELL	$65.68 - $81.01 $59.4 Million - $73.3 Million	-904,784 Reduced 1.91%	46,530,017 $3.62 Billion
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $59 Million - $107 Million	921,617 Added 1.98%	47,434,801 $3.18 Billion

Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $211 Million - $268 Million	1,909,439 Added 4.28%	46,513,184 $5.27 Billion
Q1 2024 May 10, 2024	BUY	$114.22 - $140.1 $15.6 Million - $19.1 Million	136,282 Added 0.31%	44,603,745 $6.19 Billion
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $21 Million - $34.6 Million	278,458 Added 0.63%	44,467,463 $5.52 Billion
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $8.17 Million - $13.1 Million	-94,986 Reduced 0.21%	44,189,005 $4.12 Billion
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $19.3 Million - $22.5 Million	171,858 Added 0.39%	44,283,991 $5.69 Billion
Q1 2023 Jul 14, 2023	BUY	$104.0 - $122.92 $29,952 - $35,400	288 Added 0.0%	44,112,133 $5.12 Billion
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $30.4 Million - $35.9 Million	292,009 Added 0.67%	44,111,845 $5.12 Billion
Q4 2022 Feb 10, 2023	BUY	$84.98 - $122.67 $11.7 Million - $16.9 Million	137,410 Added 0.31%	43,819,836 $4.96 Billion
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $39.1 Million - $48.2 Million	511,557 Added 1.18%	43,682,426 $3.52 Billion
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $2.22 Billion - $4.33 Billion	32,620,085 Added 309.17%	43,170,869 $3.22 Billion
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $13.2 Million - $18.3 Million	140,465 Added 1.35%	10,550,784 $5.4 Billion
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $7.93 Million - $9.94 Million	61,061 Added 0.59%	10,410,319 $5.59 Billion
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $9.97 Million - $13.4 Million	93,416 Added 0.91%	10,349,258 $5.66 Billion
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $831 Million - $1.11 Billion	10,255,842 New	10,255,842 $4.38 Billion

Others Institutions Holding DXCM

# of Institutions

1,088

Shares Held

376M

Call Options Held

6.76M

Put Options Held

7.24M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Dexcom Inc Transaction History